HK1034194A1 - Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases. - Google Patents

Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases.

Info

Publication number
HK1034194A1
HK1034194A1 HK01104754A HK01104754A HK1034194A1 HK 1034194 A1 HK1034194 A1 HK 1034194A1 HK 01104754 A HK01104754 A HK 01104754A HK 01104754 A HK01104754 A HK 01104754A HK 1034194 A1 HK1034194 A1 HK 1034194A1
Authority
HK
Hong Kong
Prior art keywords
diol
alpha
mixture
skin diseases
hydroxy acid
Prior art date
Application number
HK01104754A
Other languages
English (en)
Inventor
Agneta Ganemo
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Publication of HK1034194A1 publication Critical patent/HK1034194A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK01104754A 1997-11-25 2001-07-10 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases. HK1034194A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203681 1997-11-25
PCT/EP1998/007759 WO1999026617A1 (fr) 1997-11-25 1998-11-25 Utilisation d'un melange de diol et d'acide alpha-hydroxyle pour traiter des hyperkeratoses

Publications (1)

Publication Number Publication Date
HK1034194A1 true HK1034194A1 (en) 2001-10-19

Family

ID=8228970

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01104754A HK1034194A1 (en) 1997-11-25 2001-07-10 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases.

Country Status (22)

Country Link
US (1) US6399082B1 (fr)
EP (1) EP1032378B1 (fr)
CN (1) CN1140266C (fr)
AT (1) ATE213939T1 (fr)
AU (1) AU754420B2 (fr)
BG (1) BG64743B1 (fr)
BR (1) BR9815016A (fr)
CA (1) CA2310049C (fr)
CZ (1) CZ290165B6 (fr)
DE (1) DE69804130T2 (fr)
DK (1) DK1032378T3 (fr)
ES (1) ES2174533T3 (fr)
HK (1) HK1034194A1 (fr)
HU (1) HU226065B1 (fr)
IS (1) IS2147B (fr)
NO (1) NO320100B1 (fr)
NZ (1) NZ504458A (fr)
PL (1) PL190023B1 (fr)
PT (1) PT1032378E (fr)
SK (1) SK284505B6 (fr)
TR (1) TR200001486T2 (fr)
WO (1) WO1999026617A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5778367A (en) * 1995-12-14 1998-07-07 Network Engineering Software, Inc. Automated on-line information service and directory, particularly for the world wide web
JP2002515514A (ja) * 1998-05-21 2002-05-28 アイシス・ファーマシューティカルス・インコーポレーテッド オリゴヌクレオチドの局所送逹のための組成物及び方法
US6410036B1 (en) * 2000-05-04 2002-06-25 E-L Management Corp. Eutectic mixtures in cosmetic compositions
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
US20070189989A1 (en) * 2006-02-16 2007-08-16 Cantwell Maggie Y Cosmetic compositions and methods of making and using the compositions
WO2007101247A2 (fr) 2006-02-28 2007-09-07 Paloma Pharmaceuticals, Inc. Compositions et méthodes de traitement de maladies caractérisées par la prolifération cellulaire et l'angiogenèse
BRPI0909374A2 (pt) * 2008-03-25 2015-10-06 Paloma Pharmaceuticals Inc métodos para tratar desordens fibróticas
ES2336995B1 (es) 2008-10-13 2011-02-09 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica para el cuidado de la piel,cuero cabelludo y uñas.
CN102159191B (zh) * 2009-04-13 2014-04-02 苏鲁·苏布拉马尼·瓦南加穆迪 使用夫西地酸钠制备且加入生物聚合物的医用夫西地酸乳膏及其制备方法
EP2429559A4 (fr) * 2009-05-08 2013-08-14 Allmedic Pty Ltd Traitement de la douleur et/ou de l'inflammation et traitement et prévention d'une maladie et/ou d'une affection de la peau ou de muqueuses
CA2816872C (fr) * 2010-11-04 2019-02-12 442 Ventures, Llc Composition et procede pour le traitement d'etats cutanes
US9381187B2 (en) 2011-02-16 2016-07-05 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
GB2540764A (en) * 2015-07-24 2017-02-01 Fontus Health Ltd Topical composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
WO1994013257A1 (fr) * 1992-12-16 1994-06-23 Creative Products Resource Associates, Ltd. Lotion occlusive ou semi-occlusive pour le traitement de maladies ou de desordres cutanes
US5407958A (en) * 1993-07-30 1995-04-18 Beauticontrol Cosmetics, Inc. Therapeutic skin composition
CA2168870A1 (fr) * 1993-09-15 1995-03-23 Anthony Vincent Rawlings Methode et composition pour soins de la peau

Also Published As

Publication number Publication date
IS5505A (is) 2000-05-23
HU226065B1 (hu) 2008-04-28
DE69804130T2 (de) 2002-07-25
PL190023B1 (pl) 2005-10-31
NO20002649D0 (no) 2000-05-24
CZ20001920A3 (cs) 2001-04-11
EP1032378B1 (fr) 2002-03-06
DE69804130D1 (de) 2002-04-11
SK7432000A3 (en) 2001-05-10
PL340679A1 (en) 2001-02-12
IS2147B (is) 2006-09-15
CA2310049C (fr) 2008-02-19
CN1280495A (zh) 2001-01-17
BR9815016A (pt) 2000-10-03
TR200001486T2 (tr) 2001-07-23
ES2174533T3 (es) 2002-11-01
US6399082B1 (en) 2002-06-04
CN1140266C (zh) 2004-03-03
HUP0100066A2 (hu) 2001-08-28
AU1965999A (en) 1999-06-15
HUP0100066A3 (en) 2006-07-28
SK284505B6 (sk) 2005-05-05
ATE213939T1 (de) 2002-03-15
BG64743B1 (bg) 2006-02-28
EP1032378A1 (fr) 2000-09-06
DK1032378T3 (da) 2002-04-15
NO20002649L (no) 2000-07-24
AU754420B2 (en) 2002-11-14
WO1999026617A1 (fr) 1999-06-03
CZ290165B6 (cs) 2002-06-12
PT1032378E (pt) 2002-07-31
BG104470A (en) 2001-03-30
NO320100B1 (no) 2005-10-24
NZ504458A (en) 2002-03-01
CA2310049A1 (fr) 1999-06-03

Similar Documents

Publication Publication Date Title
HK1034194A1 (en) Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases.
IE862404L (en) Hydroxamic acid derivatives
GR3032673T3 (en) Use of an effective quantitiy of active substances for the treatment of mixed skin.
AU4883096A (en) Nitric oxide synthase inhibitors
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
AU674142B2 (en) Use of cosmetic composition
AU6178198A (en) Method of treating a tumor
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
GB2347625A (en) Agent for treating allergic or hypersensivity condition
ZA935086B (en) Skin regenerating cosmetic composition
AU7395487A (en) Inhibitors of esterase-producing micro-organisms, for use primarily in dermatology and cosmetics
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
GB9626472D0 (en) New use of comt inhibitors
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
PL332035A1 (en) Transdermal therapeutic system including an estriol-containing composition of active substances
DE69637416D1 (de) Topische anwendung von opioiden, wie morphin, zur linderung von juckreiz und hautkrankheiten sowie hautreizungen
MX9804586A (es) Uso de una composicion acida para la suavidad mejorada a la piel.
AUPO396196A0 (en) Zinc oxide & boric acid topical agent used in the treatment of hyperkeratotic lesions such as psoriasis
AU1104888A (en) Cosmetic agent and composition for skin treatment
ID16678A (id) Penggunaan asam fosforik ester untuk pengobatan fungsi penyakit-penyakit pada otak dan depresi

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20181124